cholestyramine resin has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brufau, G; Groen, AK; Out, C | 1 |
| Christie, D; Finn, L; Horslen, S; Suskind, DL; Wahbeh, G | 1 |
1 review(s) available for cholestyramine resin and Dyslipidemia
| Article | Year |
|---|---|
Bile acid sequestrants: more than simple resins.
Topics: Animals; Anion Exchange Resins; Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dyslipidemias; Energy Metabolism; Humans | 2012 |
1 other study(ies) available for cholestyramine resin and Dyslipidemia
| Article | Year |
|---|---|
A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Topics: Abnormalities, Multiple; Anticholesteremic Agents; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestyramine Resin; Dyslipidemias; Female; Humans; Ursodeoxycholic Acid | 2006 |